<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Chamorro, Ángel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Addition of Uric Acid to rt-PA Therapy May Improve Outcomes in Patients with Acute Stroke</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-10</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents results from the Efficacy Study of Combined Treatment With Uric Acid and rt-PA in Acute Ischemic Stroke [URICO-ICTUS; NCT00860366], a Phase 3 investigator-driven, multicenter, randomized, placebo-controlled efficacy study to determine whether combined treatment with uric acid and recombinant tissue plasminogen activator (rt-PA) is clinically superior to rt-PA alone.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>